CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading organization profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Organizations/healthcare

healthcare organization

Neurology, Inc

US

OPENALEX: I4210164563↗ROR: 05ne0gd95↗

People

Connected researchers

Arman SabetORCID 0000-0002-3469-6638 Berzenn UrbiExact authorship link Simon BroadleyORCID 0000-0002-9429-4307

Public evidence

1 connected articles

Study protocol for a randomised, double-blind, placebo-controlled study evaluating the Efficacy of cannabis-based Medicine Extract in slowing the disease pRogression of Amyotrophic Lateral sclerosis or motor neurone Disease: the EMERALD trial.2019 · PubMed Central Open Access

Registered research

Connected studies

A Randomised, Double-blind, Single-centre Study on the Safety, Tolerability and Efficacy of Cannabis Based Medicine Extract (MediCabilis CBD Oil) in Slowing the Disease Progression in Amyotrophic Lateral Sclerosis or Motor Neurone Disease Patientsnct03690791

Matched by exact identifiers only. Profile data: OpenAlex.

Neurology, Inc - Medical Cannabis Research Engine